Report of Foreign Issuer (6-k)
September 28 2018 - 4:51PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of, September 2018
Commission File Number 001-37652
Midatech Pharma PLC
(Translation of registrant’s name into English)
65 Innovation Drive
Milton Park
Abingdon, Oxfordshire, OX14 4RQ, United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant files or
will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SUBMITTED HEREWITH
Attached to the Registrant’s Form 6-K filing for
the month of September 2018, and incorporated by reference herein, is:
Exhibit
No.
|
|
Description
|
99.1
|
|
Midatech Pharma PLC Shareholder Circular and Notice of General Meeting.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Midatech Pharma PLC
|
|
|
|
|
|
Date: September 28, 2018
|
By:
|
/s/ Nicholas Robbins-Cherry
|
|
|
Nicholas Robbins-Cherry
|
|
|
Chief Financial Officer
|
Exhibit Index
Exhibit
No.
|
|
Description
|
99.1
|
|
Midatech Pharma PLC Shareholder Circular and Notice of General Meeting.
|
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Apr 2023 to Apr 2024